RESPIRATORY SYNCYTIAL VIRUS VACCINATION

Clinical trials for RESPIRATORY SYNCYTIAL VIRUS VACCINATION explained in plain language.

Never miss a new study

Get alerted when new RESPIRATORY SYNCYTIAL VIRUS VACCINATION trials appear

Sign up with your email to follow new studies for RESPIRATORY SYNCYTIAL VIRUS VACCINATION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Completed 1

New Multi-Virus vaccine tested in healthy adults

⭐️ VACCINE ⭐️ Completed

This early-stage study tested the safety and immune response of new combination vaccines targeting multiple respiratory viruses. Healthy adults aged 18-49 received one injection of either a flu vaccine or a combined vaccine for RSV, hMPV, and parainfluenza. Researchers monitored …

Matched conditions: RESPIRATORY SYNCYTIAL VIRUS VACCINATION

Phase: PHASE1 • Sponsor: Sanofi • Aim: ⭐️ VACCINE ⭐️

Last updated Apr 01, 2026 14:42 UTC

RESPIRATORY SYNCYTIAL VIRUS VACCINATION

Get alerted when new RESPIRATORY SYNCYTIAL VIRUS VACCINATION trials appear

New Multi-Virus vaccine tested in healthy adults